Recent Posts

TRANSCRIPTIC APPOINTS DR. JEFF FINER, M.D., PH.D. TO BOARD OF DIRECTORS

Chris Taylor on 5/10/18 10:36 AM

Life science veteran Dr. Finer is a Venture Partner with Third Rock Ventures and has 30 years research and clinical experience. 

Read More

Ginkgo Bioworks and Transcriptic selected by DARPA to accelerate biological design with $9.5 M award

Chris Taylor on 4/12/18 6:43 AM

Synergistic Discovery and Design Program to facilitate creation of a cloud-based experimental design platform and open data exchange.

Read More

NEW AND EMERGING TECHNOLOGIES AT SLAS 2018

 rovers2-1

The engineering team at Transcriptic had a great time at SLAS 2018. We saw a lot of new technologies and some great presentations!

Read More

TRANSCRIPTIC 2017 YEAR IN REVIEW

Chris Taylor on 1/16/18 12:11 PM
Read More

The LIFE of A TRANSCRIPTIC INTERN

Chris Taylor on 12/6/17 6:41 AM

 David_Macchu_Picchu v2.jpg

As we head towards the end of 2017, inquiries about 2018 intern opportunities are already ramping up. I thought it would be interesting to have one of our recent interns write about his experiences. If you're starting your hunt, whether at Transcriptic or elsewhere, here's a little bit of what you might expect:

Read More

CHAMPIONING THE SUCCESS OF WOMEN IN SCIENCE, TECHNOLOGY, ENGINEERING, MATH, AND MEDICINE

Chris Taylor on 10/10/17 8:35 AM
 
Champion cropped.jpgTo mark Ada Lovelace Day, the annual celebration that promotes women working in Science, Technology, Engineering, and Maths (STEM) Digital Science have issued a new report.

Championing The Success of Women in Science, Technology, Engineering, Maths, and Medicine” includes a collection of think pieces around current issues faced by women in STEM authored by industry leaders. The report explores areas of gender inequality and potential causes of this inequality, offering up a collection of solutions.

(Guest post from Digital Science.)

Read More

GINKGO BIOWORKS TAPS TRANSCRIPTIC’S ROBOTICS SOFTWARE TO FURTHER ACCELERATE AUTOMATION IN ORGANISM DESIGN

Chris Taylor on 10/3/17 8:12 AM

Ginkgo_Logo-768x189.jpg 

Five year, $10 million+ deal with robotic cloud lab will double Ginkgo’s foundry output; increase scale of its synthetic biology innovation

BOSTON & MENLO PARK, CALIF., Oct. 3, 2017  -- Ginkgo Bioworks, the organism company, today announced a collaboration with robotic cloud laboratory Transcriptic. Through a five year agreement valued at more than $10 million, Ginkgo will incorporate Transcriptic’s cutting-edge robotic automation software into its Boston-based foundries. The combined technologies will bolster Ginkgo’s automation capabilities and engineering capacity, strengthening its platform and cementing a foundation for continued growth.

Read More

WEBINAR SUMMARY: HOW THE INTERNET OF THINGS IS DISRUPTING SCIENCE

Chris Taylor on 8/31/17 10:10 AM

 

As part of our thought leadership webinar series, our latest broadcast discussed "How the Internet of Things is Disrupting Science." 

We covered a diverse range of topics including:

  • What the Internet of Things (IoT) is and why it’s useful to know
  • Why the IoT is foundational for science’s full potential
  • What the key challenges are facing industry
  • Predecessors to IoT and current technology approaches
  • IoT case studies from Transcriptic and TetraScience – lab tools leading the way
Read More

TRANSCRIPTIC WEBINAR: "HOW THE INTERNET OF THINGS IS DISRUPTING SCIENCE"

Chris Taylor on 8/17/17 8:00 AM

static1.squarespace.jpg

Tune into our upcoming thought leadership webinar, “How the Internet of Things is Disrupting Science” on Thursday 24th August at 4pm UK / 11am EST / 8am PST. Even if you can't attend live, a recording of the webinar will be sent to all registrants afterward.

Read More

BIOMARKER QUANTITATION IN THE CLOUD

Ben Miles on 4/4/17 6:06 PM

Mesoscale Discovery (MSD) Sector S 600 integrated with the Transcriptic robotic cloud lab

Mesoscale Discovery (MSD) Sector S 600 integrated with the Transcriptic robotic cloud lab

The Transcriptic robotic cloud lab provides a great advantage for large-scale biomarker assays, delivering consistent sample to sample processing with robotic reliability, all on demand when you need it. We’ve enabled both large pharma and small biotech to quantify DNA, RNA and proteins from hundreds or thousands of samples in an automated and programmatically driven way.

Read More